tirzepatide sglt2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Tirzepatide: A Promising Drug for

While compounded medications are not FDA-approved (only brand-name Wegovy carries FDA approval), 503A compounds meet USP standards and are prescribed by physicians nationwide

Slow motility

Right now, the platform supports 60 treatments but plans to expand to more than 100 treatments next year

doi: 10.1007/978-981-13-9589-5_3, 145 ZaarourR

61:1923-1934 [PMC free article: PMC6096619] [PubMed: 29971527] 201

Read this FDA guidance that explains the differences in microneedling devices and provides safety tips: FDA: Microneedling Devices: Getting to the Point on Benefits, Risks and Safety Did you miss the last edition of the newsletter